Evidence map›Paper›PMID 42094238›Full record

ArticleJournal of nucleic acids2026

Position-Dependent Stabilization of DNA/RNA Duplexes by Site-Specific Incorporation of LNA Nucleosides.

Elisa Tomita-Sudo, Tomoka Akita, Nae Sakimoto, Saori Tahara-Takamine, Renshin Sano, Shigenori Iwai, Junji Kawakami

Abstract read
In one paragraph

Article in Journal of nucleic acids, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Elisa Tomita-SudoKonan Laboratory for Oligonucleotide Therapeutics (KOLOT), Konan University, Kobe, Hyogo, Japan, konan-u.ac.jp.
Tomoka AkitaFrontiers of Innovative Research in Science and Technology (FIRST), Konan University, Kobe, Hyogo, Japan, konan-u.ac.jp.
Nae SakimotoKonan Laboratory for Oligonucleotide Therapeutics (KOLOT), Konan University, Kobe, Hyogo, Japan, konan-u.ac.jp.
Saori Tahara-TakamineFrontiers of Innovative Research in Science and Technology (FIRST), Konan University, Kobe, Hyogo, Japan, konan-u.ac.jp.
Renshin SanoFrontiers of Innovative Research in Science and Technology (FIRST), Konan University, Kobe, Hyogo, Japan, konan-u.ac.jp.
Shigenori IwaiKonan Laboratory for Oligonucleotide Therapeutics (KOLOT), Konan University, Kobe, Hyogo, Japan, konan-u.ac.jp.
Junji KawakamiKonan Laboratory for Oligonucleotide Therapeutics (KOLOT), Konan University, Kobe, Hyogo, Japan, konan-u.ac.jp.ORCID https://orcid.org/0009-0006-7433-2069

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Owing to their enhanced functional properties, 2

Identifiers

PMID42094238
PMCPMC13139905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.